Fox Run Management’s Haemonetics HAE Stock Holding History

Fox Run Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$575K	Buy	+7,663	New	+$492K	0.1%	419
2026 Q1	–	Sell	-17,151	Closed	-$1.37M	–	1032
2025 Q4	$1.37M	Sell	17,151 -10,710	-38%	-$720K	0.21%	101
2025 Q3	$1.36M	Buy	+27,861	New	+$1.72M	0.21%	118
2025 Q2	–	Sell	-11,191	Closed	-$711K	–	1007
2025 Q1	$711K	Buy	+11,191	New	+$761K	0.11%	324
2023 Q3	–	Sell	-14,030	Closed	-$1.19M	–	812
2023 Q2	$1.19M	Buy	+14,030	New	+$1.19M	0.34%	39
2023 Q1	–	Sell	-12,582	Closed	-$990K	–	772
2022 Q4	$990K	Buy	+12,582	New	+$1.01M	0.4%	20
2021 Q2	–	Sell	-1,889	Closed	-$210K	–	383
2021 Q1	$210K	Buy	+1,889	New	+$234K	0.38%	166
2020 Q1	–	Sell	-6,441	Closed	-$740K	–	223
2019 Q4	$740K	Buy	+6,441	New	+$779K	0.6%	7
2018 Q3	–	Sell	-4,573	Closed	-$410K	–	672
2018 Q2	$410K	Buy	4,573 +1,431	+46%	+$121K	0.13%	320
2018 Q1	$230K	Buy	+3,142	New	+$216K	0.06%	585
2017 Q3	–	Sell	-9,700	Closed	-$383K	–	745
2017 Q2	$383K	Buy	+9,700	New	+$398K	0.13%	324
2016 Q3	–	Sell	-8,200	Closed	-$238K	–	563
2016 Q2	$238K	Buy	8,200 +300	+4%	+$9.07K	0.12%	375
2016 Q1	$276K	Buy	+7,900	New	+$255K	0.18%	251

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fox Run Management's HAE Position: Q2 2026 in Review

Fox Run Management opened a new position in Haemonetics (HAE) in Q2 2026: 7,663 shares worth $575K. The stake represents 0.1% of the portfolio and ranks #419 among its holdings. This is a return to the name: Fox Run Management previously reported a position in HAE as recently as Q4 2025.

Fox Run Management first reported a position in HAE in Q1 2016 and has held it in 13 quarters since. The position peaked at $1.37M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Fox Run Management held 7,663 shares of Haemonetics worth $575K as of Q2 2026.
Haemonetics was a new Fox Run Management position in Q2 2026.
Haemonetics made up 0.1% of Fox Run Management's portfolio in Q2 2026, its #419 holding.
Fox Run Management first reported a position in Haemonetics in Q1 2016 and has held it in 13 quarters since.
Fox Run Management's Haemonetics position peaked at $1.37M in Q4 2025.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.